Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer's) or voluntary motion (in movement disorders).
This report aims to provide a comprehensive presentation of the global market for CNS Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CNS Therapeutics. This report contains market size and forecasts of CNS Therapeutics in global, including the following market information:
Global CNS Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CNS Therapeutics market was valued at US$ 78510 million in 2022 and is projected to reach US$ 107370 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Mental health segment accounted for the largest market share in 2016. It is expected to retain its dominance over the forecast period owing to developing therapeutic options for mental diseases such as personality disorders and binge eating disorders. This segment is followed by degenerative disorders segment. There is growing awareness regarding neurodegenerative diseases owing to increase in initiatives by government and nongovernment organizations, such as Alzheimer's and Related Disorders Society of India. These organizations conduct awareness campaigns and conferences, such as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on Dementia, which encourage the adoption of treatment for degenerative and mental disorders.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CNS Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CNS Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CNS Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Neurodegenerative Diseases
- Mood Disorders
- Schizophrenia
- Autism
- Depression
Global CNS Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CNS Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital Use
- Clinic Use
- Household
- Other
Global CNS Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CNS Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CNS Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CNS Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Janssen Pharmaceuticals
- Allergan
- Lundbeck
- Teva
- Camber Pharmaceuticals
- Zhejiang Haisen Pharmaceutical
- Jewim Pharmaceutical
- Cipla
- Merck Sharp & Dohme Corp.
- Eli Lilly
- GlaxoSmithKline
- Novartis
- LUPIN
- ZYDUS PHARMS
- Biogen
- Otsuka Pharmaceutical
- Astra Zeneca
- Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of CNS Therapeutics, market overview.
Chapter 2: Global CNS Therapeutics market size in revenue.
Chapter 3: Detailed analysis of CNS Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CNS Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
CNS Therapeutics Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 CNS Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CNS Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CNS Therapeutics Overall Market Size
2.1 Global CNS Therapeutics Market Size: 2022 VS 2029
2.2 Global CNS Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CNS Therapeutics Players in Global Market
3.2 Top Global CNS Therapeutics Companies Ranked by Revenue
3.3 Global CNS Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 CNS Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies CNS Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 CNS Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 CNS Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 CNS Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CNS Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Neurodegenerative Diseases
4.1.3 Mood Disorders
4.1.4 Schizophrenia
4.1.5 Autism
4.1.6 Depression
4.2 By Type - Global CNS Therapeutics Revenue & Forecasts
4.2.1 By Type - Global CNS Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global CNS Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global CNS Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CNS Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application - Global CNS Therapeutics Revenue & Forecasts
5.2.1 By Application - Global CNS Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global CNS Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global CNS Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CNS Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global CNS Therapeutics Revenue & Forecasts
6.2.1 By Region - Global CNS Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global CNS Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global CNS Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CNS Therapeutics Revenue, 2018-2029
6.3.2 US CNS Therapeutics Market Size, 2018-2029
6.3.3 Canada CNS Therapeutics Market Size, 2018-2029
6.3.4 Mexico CNS Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CNS Therapeutics Revenue, 2018-2029
6.4.2 Germany CNS Therapeutics Market Size, 2018-2029
6.4.3 France CNS Therapeutics Market Size, 2018-2029
6.4.4 U.K. CNS Therapeutics Market Size, 2018-2029
6.4.5 Italy CNS Therapeutics Market Size, 2018-2029
6.4.6 Russia CNS Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries CNS Therapeutics Market Size, 2018-2029
6.4.8 Benelux CNS Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CNS Therapeutics Revenue, 2018-2029
6.5.2 China CNS Therapeutics Market Size, 2018-2029
6.5.3 Japan CNS Therapeutics Market Size, 2018-2029
6.5.4 South Korea CNS Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia CNS Therapeutics Market Size, 2018-2029
6.5.6 India CNS Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CNS Therapeutics Revenue, 2018-2029
6.6.2 Brazil CNS Therapeutics Market Size, 2018-2029
6.6.3 Argentina CNS Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CNS Therapeutics Revenue, 2018-2029
6.7.2 Turkey CNS Therapeutics Market Size, 2018-2029
6.7.3 Israel CNS Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia CNS Therapeutics Market Size, 2018-2029
6.7.5 UAE CNS Therapeutics Market Size, 2018-2029
7 CNS Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer CNS Therapeutics Major Product Offerings
7.1.4 Pfizer CNS Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Janssen Pharmaceuticals
7.2.1 Janssen Pharmaceuticals Company Summary
7.2.2 Janssen Pharmaceuticals Business Overview
7.2.3 Janssen Pharmaceuticals CNS Therapeutics Major Product Offerings
7.2.4 Janssen Pharmaceuticals CNS Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Janssen Pharmaceuticals Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan CNS Therapeutics Major Product Offerings
7.3.4 Allergan CNS Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Allergan Key News & Latest Developments
7.4 Lundbeck
7.4.1 Lundbeck Company Summary
7.4.2 Lundbeck Business Overview
7.4.3 Lundbeck CNS Therapeutics Major Product Offerings
7.4.4 Lundbeck CNS Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Lundbeck Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva CNS Therapeutics Major Product Offerings
7.5.4 Teva CNS Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Camber Pharmaceuticals
7.6.1 Camber Pharmaceuticals Company Summary
7.6.2 Camber Pharmaceuticals Business Overview
7.6.3 Camber Pharmaceuticals CNS Therapeutics Major Product Offerings
7.6.4 Camber Pharmaceuticals CNS Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Camber Pharmaceuticals Key News & Latest Developments
7.7 Zhejiang Haisen Pharmaceutical
7.7.1 Zhejiang Haisen Pharmaceutical Company Summary
7.7.2 Zhejiang Haisen Pharmaceutical Business Overview
7.7.3 Zhejiang Haisen Pharmaceutical CNS Therapeutics Major Product Offerings
7.7.4 Zhejiang Haisen Pharmaceutical CNS Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Zhejiang Haisen Pharmaceutical Key News & Latest Developments
7.8 Jewim Pharmaceutical
7.8.1 Jewim Pharmaceutical Company Summary
7.8.2 Jewim Pharmaceutical Business Overview
7.8.3 Jewim Pharmaceutical CNS Therapeutics Major Product Offerings
7.8.4 Jewim Pharmaceutical CNS Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Jewim Pharmaceutical Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla CNS Therapeutics Major Product Offerings
7.9.4 Cipla CNS Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Cipla Key News & Latest Developments
7.10 Merck Sharp & Dohme Corp.
7.10.1 Merck Sharp & Dohme Corp. Company Summary
7.10.2 Merck Sharp & Dohme Corp. Business Overview
7.10.3 Merck Sharp & Dohme Corp. CNS Therapeutics Major Product Offerings
7.10.4 Merck Sharp & Dohme Corp. CNS Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Merck Sharp & Dohme Corp. Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly CNS Therapeutics Major Product Offerings
7.11.4 Eli Lilly CNS Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Summary
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline CNS Therapeutics Major Product Offerings
7.12.4 GlaxoSmithKline CNS Therapeutics Revenue in Global Market (2018-2023)
7.12.5 GlaxoSmithKline Key News & Latest Developments
7.13 Novartis
7.13.1 Novartis Company Summary
7.13.2 Novartis Business Overview
7.13.3 Novartis CNS Therapeutics Major Product Offerings
7.13.4 Novartis CNS Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Novartis Key News & Latest Developments
7.14 LUPIN
7.14.1 LUPIN Company Summary
7.14.2 LUPIN Business Overview
7.14.3 LUPIN CNS Therapeutics Major Product Offerings
7.14.4 LUPIN CNS Therapeutics Revenue in Global Market (2018-2023)
7.14.5 LUPIN Key News & Latest Developments
7.15 ZYDUS PHARMS
7.15.1 ZYDUS PHARMS Company Summary
7.15.2 ZYDUS PHARMS Business Overview
7.15.3 ZYDUS PHARMS CNS Therapeutics Major Product Offerings
7.15.4 ZYDUS PHARMS CNS Therapeutics Revenue in Global Market (2018-2023)
7.15.5 ZYDUS PHARMS Key News & Latest Developments
7.16 Biogen
7.16.1 Biogen Company Summary
7.16.2 Biogen Business Overview
7.16.3 Biogen CNS Therapeutics Major Product Offerings
7.16.4 Biogen CNS Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Biogen Key News & Latest Developments
7.17 Otsuka Pharmaceutical
7.17.1 Otsuka Pharmaceutical Company Summary
7.17.2 Otsuka Pharmaceutical Business Overview
7.17.3 Otsuka Pharmaceutical CNS Therapeutics Major Product Offerings
7.17.4 Otsuka Pharmaceutical CNS Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Otsuka Pharmaceutical Key News & Latest Developments
7.18 Astra Zeneca
7.18.1 Astra Zeneca Company Summary
7.18.2 Astra Zeneca Business Overview
7.18.3 Astra Zeneca CNS Therapeutics Major Product Offerings
7.18.4 Astra Zeneca CNS Therapeutics Revenue in Global Market (2018-2023)
7.18.5 Astra Zeneca Key News & Latest Developments
7.19 Takeda
7.19.1 Takeda Company Summary
7.19.2 Takeda Business Overview
7.19.3 Takeda CNS Therapeutics Major Product Offerings
7.19.4 Takeda CNS Therapeutics Revenue in Global Market (2018-2023)
7.19.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CNS Therapeutics Market Opportunities & Trends in Global Market
Table 2. CNS Therapeutics Market Drivers in Global Market
Table 3. CNS Therapeutics Market Restraints in Global Market
Table 4. Key Players of CNS Therapeutics in Global Market
Table 5. Top CNS Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CNS Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CNS Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies CNS Therapeutics Product Type
Table 9. List of Global Tier 1 CNS Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CNS Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global CNS Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CNS Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CNS Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global CNS Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CNS Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CNS Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global CNS Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CNS Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CNS Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CNS Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CNS Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CNS Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CNS Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CNS Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CNS Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CNS Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CNS Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CNS Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CNS Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer CNS Therapeutics Product Offerings
Table 32. Pfizer CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Janssen Pharmaceuticals Company Summary
Table 35. Janssen Pharmaceuticals CNS Therapeutics Product Offerings
Table 36. Janssen Pharmaceuticals CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Janssen Pharmaceuticals Key News & Latest Developments
Table 38. Allergan Company Summary
Table 39. Allergan CNS Therapeutics Product Offerings
Table 40. Allergan CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Allergan Key News & Latest Developments
Table 42. Lundbeck Company Summary
Table 43. Lundbeck CNS Therapeutics Product Offerings
Table 44. Lundbeck CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Lundbeck Key News & Latest Developments
Table 46. Teva Company Summary
Table 47. Teva CNS Therapeutics Product Offerings
Table 48. Teva CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Camber Pharmaceuticals Company Summary
Table 51. Camber Pharmaceuticals CNS Therapeutics Product Offerings
Table 52. Camber Pharmaceuticals CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Camber Pharmaceuticals Key News & Latest Developments
Table 54. Zhejiang Haisen Pharmaceutical Company Summary
Table 55. Zhejiang Haisen Pharmaceutical CNS Therapeutics Product Offerings
Table 56. Zhejiang Haisen Pharmaceutical CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Zhejiang Haisen Pharmaceutical Key News & Latest Developments
Table 58. Jewim Pharmaceutical Company Summary
Table 59. Jewim Pharmaceutical CNS Therapeutics Product Offerings
Table 60. Jewim Pharmaceutical CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Jewim Pharmaceutical Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla CNS Therapeutics Product Offerings
Table 64. Cipla CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Cipla Key News & Latest Developments
Table 66. Merck Sharp & Dohme Corp. Company Summary
Table 67. Merck Sharp & Dohme Corp. CNS Therapeutics Product Offerings
Table 68. Merck Sharp & Dohme Corp. CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Sharp & Dohme Corp. Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly CNS Therapeutics Product Offerings
Table 72. Eli Lilly CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline CNS Therapeutics Product Offerings
Table 76. GlaxoSmithKline CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis CNS Therapeutics Product Offerings
Table 80. Novartis CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. LUPIN Company Summary
Table 83. LUPIN CNS Therapeutics Product Offerings
Table 84. LUPIN CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. LUPIN Key News & Latest Developments
Table 86. ZYDUS PHARMS Company Summary
Table 87. ZYDUS PHARMS CNS Therapeutics Product Offerings
Table 88. ZYDUS PHARMS CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. ZYDUS PHARMS Key News & Latest Developments
Table 90. Biogen Company Summary
Table 91. Biogen CNS Therapeutics Product Offerings
Table 92. Biogen CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Biogen Key News & Latest Developments
Table 94. Otsuka Pharmaceutical Company Summary
Table 95. Otsuka Pharmaceutical CNS Therapeutics Product Offerings
Table 96. Otsuka Pharmaceutical CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. Otsuka Pharmaceutical Key News & Latest Developments
Table 98. Astra Zeneca Company Summary
Table 99. Astra Zeneca CNS Therapeutics Product Offerings
Table 100. Astra Zeneca CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 101. Astra Zeneca Key News & Latest Developments
Table 102. Takeda Company Summary
Table 103. Takeda CNS Therapeutics Product Offerings
Table 104. Takeda CNS Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 105. Takeda Key News & Latest Developments
List of Figures
Figure 1. CNS Therapeutics Segment by Type in 2022
Figure 2. CNS Therapeutics Segment by Application in 2022
Figure 3. Global CNS Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CNS Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CNS Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CNS Therapeutics Revenue in 2022
Figure 8. By Type - Global CNS Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global CNS Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global CNS Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CNS Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global CNS Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CNS Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global CNS Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America CNS Therapeutics Revenue Market Share, 2018-2029
Figure 16. US CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CNS Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CNS Therapeutics Revenue Market Share, 2018-2029
Figure 28. China CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CNS Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CNS Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CNS Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Janssen Pharmaceuticals CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Allergan CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lundbeck CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Camber Pharmaceuticals CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zhejiang Haisen Pharmaceutical CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jewim Pharmaceutical CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cipla CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Sharp & Dohme Corp. CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. GlaxoSmithKline CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Novartis CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. LUPIN CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. ZYDUS PHARMS CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Biogen CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Otsuka Pharmaceutical CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Astra Zeneca CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Takeda CNS Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global CNS Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 03-Oct-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global CNS Therapeutics market:
According to our latest research, the global CNS Therapeutics market looks promising in the next 5 years. As of 2022, the global CNS Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Central nervous system (CNS) disease is a widespread condition in which the brain does not function properly, limiting health and function. The......
Global CNS Therapeutics Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 117
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Central Nervous System Disorders Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application
Published: 18-Apr-2023 Price: US 3500 Onwards Pages: 131
This report describes the global market size of Central Nervous System Disorders Therapeutics from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2028. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for ......
Global CNS Therapeutics Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 16-Mar-2023 Price: US 3260 Onwards Pages: 117
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Global CNS Therapeutics Market Research Report 2023
Published: 06-Feb-2023 Price: US 2900 Onwards Pages: 103
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
CNS Therapeutics Market, Global Outlook and Forecast 2023-2029
Published: 03-Feb-2023 Price: US 3250 Onwards Pages: 100
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Global Central Nervous System Disorders Therapeutics Market Growth (Status and Outlook) 2023-2029
Published: 02-Feb-2023 Price: US 3660 Onwards Pages: 88
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
LPI (LP Information)' newest research report, the "Central Nervous System Disorders Therapeutics Industry Forecast" looks at past sales and reviews total world Central Nervous System Disorders Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Central Nervous System Disorder......
Global Central Nervous System Disorders Therapeutics Market Research Report 2023
Published: 31-Jan-2023 Price: US 2900 Onwards Pages: 84
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
Highlights
The global Central Nervous System Disorders Therapeutics market was valued at US$ 134580 million in 2022 and is anticipated to reach US$ 169200 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating......
Central Nervous System Disorders Therapeutics Market, Global Outlook and Forecast 2023-2029
Published: 31-Jan-2023 Price: US 3250 Onwards Pages: 69
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and ma......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
